Innogenetics achieves CE mark for new human papillomavirus (HPV) genotyping test

04-Jun-2008 - Innogenetics announced that it has received CE marking for its new and expanded HPV genotyping test, the INNO-LiPA HPV Genotyping Extra. The new generation kit allows the genotyping of 28 different HPV genotypes, of which 18 are high-risk types for the possible development of cervical cancer. The ...

QIAGEN and BioHelix Enter Into Licensing Agreement

Helicase-dependent isothermal DNA amplification system provides new assay technology capabilities for QIAGEN's assay automation platforms

05-May-2008 - QIAGEN and privately held BioHelix have announced that they have entered into a non-exclusive worldwide license and supply agreement for BioHelix's proprietary Helicase Dependent Amplification technology (HDA). HDA is a versatile assay technology to detect and analyze biological target molecules ...

QIAGEN Acquires Genaco Biomedical Products, Inc.

31-Oct-2006 - QIAGEN N.V. announced that it acquired all outstanding shares of Genaco Biomedical Products, Inc. (Genaco). Genaco is an early-stage company applying a proprietary PCR-based multiplexing technology, Tem-PCR, to develop Templex(TM) molecular diagnostic tests. Genaco is based in Huntsville, ...

QIAGEN Launches the First Validated Portfolio Linking Genome-Wide RNAi and qPCR-Based Gene Expression Assays

27-Apr-2005 - QIAGEN N.V. announced the launch of what it believes is the world's first and largest product portfolio for integrated genome-wide RNAi and SYBR(R) Green-based RT-PCR. The offering addresses a critical need in research and drug development. QIAGEN believes that this new offering represents a ...

Cambrex and Epoch Biosciences Announce Licensing Deal For Rapid Microbial Detection

15-Oct-2004 - Cambrex Bio Science Walkersville, Inc., a subsidiary of Cambrex Corporationand Epoch Biosciences, Inc. , a provider of proprietary products that accelerate genomic analysis, are pleased to announce that they have entered into a worldwide license whereby Cambrex Bioproducts will incorporate ...

Proligo and RNAx GmbH Announce Collaboration in the Area of RNAi

27-Apr-2004 - Paris and Berlin, April 26, 2004 - Proligo (CO, USA) and RNAx announced the signing of a collaboration agreement in the area of RNAi. Under the terms of the agreement, RNAx provides Proligo with access to RNA interference functional validation technology (RNAi). Proligo will employ this ...

Myriad Genetics and Abbott Laboratories Expand Collaboration

08-Jan-2004 - SALT LAKE CITY, Myriad Genetics, Inc., and Abbott Laboratories, Inc. have expanded their strategic alliance to include a broad new pharmacogenetics program, the Company announced today. The research collaboration will focus on identifying genetic variation within the general population around ...

Epoch Biosciences and QIAGEN Announce Global Marketing Agreement

Epoch to License and Supply MGB Eclipse™ Technologies For Gene Expression Products

08-Nov-2002 - Epoch Biosciences, Inc. and QIAGEN N.V., today announced that QIAGEN will become a co-exclusive worldwide sales and marketing partner to the research field for products that incorporate Epoch Biosciences' MGB Eclipse™ Probe Systems for real-time measurement of gene expression. Epoch will ...

SEQUENOM Launches Online E-Commerce Platform To Accelerate Large-Scale Genetic Studies

06-May-2002 - SAN DIEGO, May 1 - SEQUENOM, Inc. a discovery genetics company, today announced the launch of its new RealSNP.com(TM) e-commerce platform, which offers online access to SEQUENOM's industry leading collection of single nucleotide polymorphism (SNP) assays for accelerating large-scale genetic ...

Varian, Inc. Introduces Its First BioStandard Used to Validate DHPLC Systems

10-Apr-2002 - PALO ALTO, Calif., - Varian, Inc. announced that the company has begun manufacturing biomolecular standards for the first time, as part of its BioSolutions(TM) line of products. The new DYS271 DHPLC Standard is ready-made and designed for easy, routine validation of denaturing high performance ...